Beyond cost-effectiveness, analysis. Value-based pricing and result-oriented financing as a pathway to sustainability for the national health system in Spain

Más allá Del análisis Coste-Efectividad. Precios Basados en el Valor y Financiación Orientada a Resultados Como Vía de Sostenibilidad Para el SNS en España

Authors

  • Alvaro Hidalgo-Vega Facultad de Ciencias Jurídicas y Sociales de Toledo, Departamento de Análisis Económico y Finanzas, Universidad de Castilla-La Mancha, Madrid - Spain

DOI:

https://doi.org/10.33393/grhta.2017.377

Keywords:

Cost-effectiveness, Economic evaluation, Funding, Health results, Pharmacoeconomics, Value

Abstract

The editorial addresses the current use of economic evaluation in the assessment and potential funding and reimbursement of health technologies. Cost-effectiveness ratio and the acceptability thresholds are analyzed, pointing out the limitations that the current approach has for capturing the value of new technologies. A potential shift from National Health Systems to value-based prices is discussed, with a focus on health economics outcomes where multi-criteria analyses can be a complementary tool to traditional cost-effectiveness approaches.

Most read articles by the same author(s)